Source: UHOD: International Journal of Hematology & Oncology / Uluslararasi Hematoloji Onkoloji Dergisi. Jun2009, Vol. 19 Issue 2, p63-68. 6p. 6 Charts, 1 Graph.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Evaluation of the Efficacy of Prolonged Administration of Temozolomide in the Treatment of Advanced Non-Small Cell Lung Cancer.

Authors : Karim, Nagla Abdel¹; Mehta, Apurva¹; Musaad, Salma¹

Source: Cancer Therapy. 2009, Vol. 7, p409-415. 7p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Küçük Hücreli Dışı Akciğer Kanserinde Hedefe Yönelik Tedavi.

Authors : Oztop, Ilhan¹

Source: UHOD: International Journal of Hematology & Oncology / Uluslararasi Hematoloji Onkoloji Dergisi. Dec2009, Vol. 19 Issue 3, p184-194. 11p. 3 Charts.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Prognostic factors and long term results of neo adjuvant therapy followed by surgery in stage IIIA N2 non-small cell lung cancer patients.

Authors : Jing Li¹ ; Chun-Hua Dai²; Shun-Bing Shi³

Source: Annals of Thoracic Medicine. Oct2009, Vol. 4 Issue 4, p201-207. 7p. 3 Charts, 4 Graphs.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Prognostic significance of urokinase plasminogen activator receptor and its cleaved forms in blood from patients with non-small cell lung cancer.

Authors : ALMASI, CHARLOTTE ELBERLING¹ ; HØYER-HANSEN, GUNILLA¹; CHRISTENSEN, IB JARLE¹

Source: APMIS. Oct2009, Vol. 117 Issue 10, p755-761. 7p. 2 Charts, 1 Graph.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

A PROLIFERATION-INDUCING LIGAND: A NEW BIOMARKER FOR NON-SMALL CELL LUNG CANCER.

Authors : Sun, Baolan¹ (AUTHOR); Wang, Huimin¹ (AUTHOR); Wang, Xing¹ (AUTHOR)

Source: Experimental Lung Research. Aug2009, Vol. 35 Issue 6, p486-500. 15p. 1 Color Photograph, 2 Charts, 2 Graphs.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Patient willingness to undergo chemotherapy and thoracic radiotherapy for locally advanced non-small cell lung cancer.

Authors : Hirose, Takashi¹ ; Yamaoka, Toshimitsu¹; Ohnishi, Tsukasa¹

Source: Psycho-Oncology. May2009, Vol. 18 Issue 5, p483-489. 7p. 4 Charts, 2 Graphs.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Randomized phase II trial of gemcitabine and either day 1 or day 8 carboplatin for advanced non-small-cell lung cancer: Is thrombocytopenia predictable?

Authors : CROMBIE, Cathy¹; BURNS, W. Ivon²; KARAPETIS, Christos³

Source: Asia Pacific Journal of Clinical Oncology. Mar2009, Vol. 5 Issue 1, p24-31. 8p. 5 Charts, 2 Graphs.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Phase II Trial of Thalidomide, Irinotecan and Gemcitabine in Chemonaive Patients with Advanced Non-Small Cell Lung Cancer.

Authors : Jazieh, A. R.^1,2 (AUTHOR); Komrokji, R.¹ (AUTHOR); Gupta, A.¹ (AUTHOR)

Source: Cancer Investigation. Nov2009, Vol. 27 Issue 9, p932-936. 5p. 3 Charts, 2 Graphs.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

No Study Left Behind: A Network Meta-Analysis in Non–Small-Cell Lung Cancer Demonstrating the Importance of Considering All Relevant Data.

Authors : Hawkins, Neil¹ ; Scott, David A.¹; Woods, Beth S.¹

Source: Value in Health. Sep2009, Vol. 12 Issue 6, p996-1003. 8p. 3 Charts, 5 Graphs.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Küçük Hücreli Dışı Akciğer Kanserinde Komorbiditenin Prognostik Önemi ve Diğer Prognostik Faktörlerle İlişkisi.

Evaluation of the Efficacy of Prolonged Administration of Temozolomide in the Treatment of Advanced Non-Small Cell Lung Cancer.

Küçük Hücreli Dışı Akciğer Kanserinde Hedefe Yönelik Tedavi.

Prognostic factors and long term results of neo adjuvant therapy followed by surgery in stage IIIA N2 non-small cell lung cancer patients.

Prognostic significance of urokinase plasminogen activator receptor and its cleaved forms in blood from patients with non-small cell lung cancer.

A PROLIFERATION-INDUCING LIGAND: A NEW BIOMARKER FOR NON-SMALL CELL LUNG CANCER.

Patient willingness to undergo chemotherapy and thoracic radiotherapy for locally advanced non-small cell lung cancer.

Randomized phase II trial of gemcitabine and either day 1 or day 8 carboplatin for advanced non-small-cell lung cancer: Is thrombocytopenia predictable?

Phase II Trial of Thalidomide, Irinotecan and Gemcitabine in Chemonaive Patients with Advanced Non-Small Cell Lung Cancer.

No Study Left Behind: A Network Meta-Analysis in Non–Small-Cell Lung Cancer Demonstrating the Importance of Considering All Relevant Data.

اتصل بنا

اتبع